{"product_id":"complete-conference-management-26th-annual-san-diego-heart-failure-winter-symposium-2026","title":"Complete Conference Management 26th Annual San Diego Heart Failure Winter Symposium 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, internists, primary care physicians, family medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSYMPOSIUM OBJECTIVES:\u003c\/h3\u003e\n\u003cp\u003eSummarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.\u003c\/p\u003e\n\u003cp\u003eDefine how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.\u003c\/p\u003e\n\u003cp\u003eTARGET AUDIENCE\u003c\/p\u003e\n\u003cp\u003eThis course is designed for cardiologists, internists, primary care physicians, nurses, PA’s, PharmD’s and all other allied healthcare professionals with an interest in heart failure.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e01 Recognizing the Cardio-Renal-Metabolic Syndrome (CRMS) and It’s Importance in Practice\u003c\/p\u003e\n\u003cp\u003e02 Role of SGLT2 Inhibitors in Treating Patients with DCRM Conditions\u003c\/p\u003e\n\u003cp\u003e04 Advances in the Management of Patients with Dyslipidemia\u003c\/p\u003e\n\u003cp\u003e05 Use of Finerenone To Prevent CV Disease, CKD and Heart Failure\u003c\/p\u003e\n\u003cp\u003e06 Moderated Panel\u003c\/p\u003e\n\u003cp\u003e07 Percutaneous Valve Replacement and Repair\u003c\/p\u003e\n\u003cp\u003e08 Advances in the Management of Pulmonary Arterial Hypertension\u003c\/p\u003e\n\u003cp\u003e09 Recognizing and Treating Patients with Amyloidosis\u003c\/p\u003e\n\u003cp\u003e10 Advances in the Management of Patients with Hypertrophic Cardiomyopathy\u003c\/p\u003e\n\u003cp\u003e11 Managing Patients with Cardiac Sarcoidosis and Other Infiltrative Diseases\u003c\/p\u003e\n\u003cp\u003e12 Moderated Panel Discussion\u003c\/p\u003e\n\u003cp\u003e13 Introduction to Rare Diseases and Gene Therapy\u003c\/p\u003e\n\u003cp\u003e14 Gene Therapy from Bench to Bedside\u003c\/p\u003e\n\u003cp\u003e15 Genetic Testing – Who, What, When and Why\u003c\/p\u003e\n\u003cp\u003e16 Genetic Counseling\u003c\/p\u003e\n\u003cp\u003e17 Gene Therapy for Genetic Cardiomyopathies\u003c\/p\u003e\n\u003cp\u003e18 Gene Therapy for Lysosomal Storage Diseases\u003c\/p\u003e\n\u003cp\u003e19 Genetic Diseases from the Patient Perspective\u003c\/p\u003e\n\u003cp\u003e21 Advances in the Management of Patients with Symptomatic HFrEF\u003c\/p\u003e\n\u003cp\u003e22 Emerging Approaches for Managing Patients with Symptomatic HFpEF\u003c\/p\u003e\n\u003cp\u003e23 Monitoring Devices To Identify and Treat Congestion\u003c\/p\u003e\n\u003cp\u003e24 What’s New in 2026\u003c\/p\u003e\n\u003cp\u003e26 Recognizing Preshock-The Early Warning Signs\u003c\/p\u003e\n\u003cp\u003e27 Diagnosis and Initial Management of Cardiogenic Shock\u003c\/p\u003e\n\u003cp\u003e28 Mechanical Circulatory Support in Escalating Shock\u003c\/p\u003e\n\u003cp\u003e29 Surgical Intervention for Advanced Cardiogenic Shock\u003c\/p\u003e\n\u003cp\u003e31 Emerging Approaches for Categorizing and Treating Patients with Myocarditis and Chronic Pericarditis\u003c\/p\u003e\n\u003cp\u003e32 Approaches for Managing Patients with Atrial Fibrillation and Preventing Thromboembolism\u003c\/p\u003e\n\u003cp\u003e33 Chemotherapy Induced Cardiomyopathy- Prevalence, Risk and Prevention\u003c\/p\u003e\n\u003cp\u003e34 Identifying Patients at Risk of Sudden Cardiac Death\u003c\/p\u003e\n\u003cp\u003e35 Who Is A Candidate for Advanced Therapies\u003c\/p\u003e\n\u003cp\u003e36 Outcomes From Cardiac Transplantation and LVAD\u003c\/p\u003e\n\u003cp\u003e38 Case Vignettes Cardiogenic shock in pregnancy\u003c\/p\u003e\n\u003cp\u003e39 Clinical Vignettes Wettersten_Case\u003c\/p\u003e\n\u003cp\u003e40 Case Vignettes Dixit_Case\u003c\/p\u003e\n\u003cp\u003e41 Case Vignettes Shen_Case\u003c\/p\u003e\n\u003cp\u003e42 Case Vignettes Taub_Cases\u003c\/p\u003e\n\u003cp\u003e43 Case Vignettes\u003c\/p\u003e\n\u003cp\u003eCase Vignettes Day 1\u003c\/p\u003e\n\u003cp\u003eClinical Vignettes Day 2\u003c\/p\u003e\n\u003cp\u003eSession I-Defining and Managing the Cardio-Renal-Metabolic Syndrome\u003c\/p\u003e\n\u003cp\u003eSession II- Cardio-Oncology and Pulmonary Arterial Hypertension\u003c\/p\u003e\n\u003cp\u003eSession III- Amyloid and Other Infiltrative Heart Disease, Hypertrophic Cardiomyopathy and HFpEF\u003c\/p\u003e\n\u003cp\u003eSession IV- Rare Diseases and Gene Therapy\u003c\/p\u003e\n\u003cp\u003eSession V- Managing Patients with Stage C Heart Failure\u003c\/p\u003e\n\u003cp\u003eSession VI- Shock and Pre-Shock- Diagnosis and Management\u003c\/p\u003e\n\u003cp\u003eSession VII- Myocarditis, Pericarditis, Arrhythmias, Treating Valvular Heart Disease and Preventing Sudden Cardiac…\u003c\/p\u003e\n\u003cp\u003eSession VIII- Advanced Therapies for Heart Failure\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405752684740,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Complete-Conference-Management-26th-Annual-San-Diego-Heart-Failure-Winter-Symposium-2026.jpg?v=1784215673","url":"https:\/\/medicalcoursespro.com\/products\/complete-conference-management-26th-annual-san-diego-heart-failure-winter-symposium-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}